Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 34, Issue 1, Pages 194-199Publisher
WILEY
DOI: 10.1002/eji.200324257
Keywords
CTL; cross-priming; MHC; virus; tumor
Categories
Funding
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000814, Z01AI000814] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Cross-priming refers to the activation of naive CD8(+) T cells by antigen-presenting cells that have acquired nominal antigens from another cell. The biological relevance of cross-priming of CD8(+)T cells has recently been challenged (Zinkernagel, R. M., Eur J. Immunol. 2002. 32: 2385-2392), on the basis that responses are weak or poorly quantitated, and the determinants recognized are undefined. Here we show that cross-priming is a robust process that elicits vigorous primary responses to multiple pepticles in two well-defined systems. Our findings support the relevance of cross-priming in CD8(+) T cell responses to viruses and tumor cells, and demonstrate that cross-priming elicits CD8(+) T cells to determinants generated by the endogenous processing pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available